A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions [4]

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 70, Issue 1, 2002, Pages 38-43

  Dawlah, Zubaer M ^a   Cabrera, Aloys ^a   Ahern, Kathleen ^a   Levis, William R ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; CORTICOSTEROID; DAPSONE; PENTOXIFYLLINE; PREDNISONE; RIFAMPICIN; THALIDOMIDE;

ABDOMINAL DISEASE; ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ERYTHEMA NODOSUM LEPROSUM; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; LEPROSY; LETTER; MALE; MYCOBACTERIUM LEPRAE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS NODULE; TERATOGENICITY; TREATMENT OUTCOME; VERTIGO;

ADULT; AGED; ERYTHEMA NODOSUM; FEMALE; HUMANS; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; MALE; MIDDLE AGED; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036317728     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (27)

1. 2 by homan polymorphonuclear leukocytes in vitro
2. Tumor necrosis factor production in patients with leprosy
3. Pentoxifylline and analogues: Effects on normal and diseased granulocyte function in vitro
4. Pentoxifylline suppression of tumor necrosis factor gene transcription
5. Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-alpha and interleukin-1 beta by human mononuclear cells
6. The effects of tumor necrosis factor and their selective inhibition by ibuprofen
7. Tumor necrosis factor induced mortality is reversed with cycloxygenase inhibition
8. Inhibition of granulocyte adhesion by pentoxiphylline
9. Suppression of T cell proliferation by Mycobacterium leprae and its products: The role of lipopolysaccharide
10. Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation
11. Role of different blood cell types in blood rheology
12. The use of pentoxifylline in the treatment of Type 2 reactional episodes in leprosy
13. Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions
14. Pentoxifylline downregulates nitric oxide tumor necrosis factor-α induced by mycobacterial lipoarabinomannan in a macrophage cell line
15. Classification of leprosy according to immunity. A five-group system
16. Pentoxifylline
17. The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum
18. Serum levels of tumor necrosis factor-alpha and interleukin-1β during leprosy reactional states
19. Pentoxifylline aggravates impairment in tumor necrosis factor-alpha secretion and increases mycobacterial load in macrophages from AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection
20. Mycobacterial lipoarabinomannan induces nitric oxide and tumor necrosis factor alpha production in a macrophage cell line: Down regulation of taurine chloramine
21. Tumor necrosis factor: Status in reactions in leprosy before and after treatment
22. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline
23. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline
24. Pentoxifylline inhibits the inflammatory effects of endotoxin and endotoxin induced cytokines on neutrophil function
25. Effect of pentoxifylline on cytokine- and eicosanoid induced acute pulmonary hypertension in piglets
26. Effect of zafirlukast on leprosy reactions
27. Inhibition of endogenous TNF formation by pentoxifylline